Frank Buchholz
Technische Universität Dresden
H-index: 62
Europe-Germany
Top articles of Frank Buchholz
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Activation of recombinases at specific DNA loci by zinc-finger domain insertions | Nature Biotechnology | Liliya Mukhametzyanova Lukas Theo Schmitt Julia Torres-Rivera Teresa Rojo-Romanos Felix Lansing | 2024/1/31 |
Abstract LB116: Antibody-TLR3 agonist-conjugates induce innate immune responses and immune memory eradicating experimental EGFRvIII-positive tumors | Cancer Research | Achim Temme Alexander Hagstotz Isabell Schau Michael Seifert Duran Sürün | 2024/4/5 |
Nucleolar protein TAAP1/C22orf46 confers pro-survival signaling in non-small cell lung cancer | Life Science Alliance | Mirko Theis Marietta Döring Melanie Brux Maciej Paszkowski-Rogacz Pedro M Guillem-Gloria Frank Buchholz | 2024/1/16 |
Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1 | Plos one | Niklas Beschorner Paul Künzle Maike Voges Ilona Hauber Daniela Indenbirken | 2024/3/8 |
Towards targeted Cas9 (CRISPR‐Cas) delivery: Preparation of IgG antibody‐Cas9 conjugates using a split intein | Journal of Peptide Science | Tim Pasch Nicole Bäumer Sebastian Bäumer Frank Buchholz Henning D Mootz | 2024/3/6 |
Hematopoietic Stem/Progenitor Cells and Engineering: IMPACT OF MIRNA-30A-5P GENE KNOCK OUT ON THE PROLIFERATION AND DIFFERENTIATION CAPACITY OF ERYTHROBLAST CELL LINE “IMBMEP … | Cytotherapy | IN Muhsen H Cruz H Zhang SG Thakkar B Grilley | 2022/5/1 |
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer | Cancers | Daniel Martin Klotz Franziska Maria Schwarz Anna Dubrovska Kati Schuster Mirko Theis | 2023/7/25 |
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma | Nature Communications | Konstantin Okonechnikov Aylin Camgöz Owen Chapman Sameena Wani Donglim Esther Park | 2023/4/21 |
Precise excision of HTLV-1 provirus with a designer-recombinase | Molecular Therapy | Teresa Rojo-Romanos Janet Karpinski Sebastian Millen Niklas Beschorner Florian Simon | 2023/7/5 |
Methods and means for genetic alteration of genomes utilizing designer dna recombining enzymes | 2023/12/19 | ||
Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLs | Blood Advances | Elisa Donato Nadia Correia Carolin Andresen Darja Karpova Roberto Würth | 2023/3/28 |
Site-specific recombinases for efficient and specific genome editing | 2023/6/15 | ||
Quantification of evolved DNA-editing enzymes at scale with DEQSeq | Genome Biology | Lukas Theo Schmitt Aksana Schneider Jonas Posorski Felix Lansing Milica Jelicic | 2023/11/6 |
Genom-Editierung ohne die DNA-Sequenz zu verändern—geht das? | Pascal Y Schönberg Li Ding Frank Buchholz | 2023/2 | |
Discovery and characterization of novel Cre-type tyrosine site-specific recombinases for advanced genome engineering | Nucleic Acids Research | Milica Jelicic Lukas Theo Schmitt Maciej Paszkowski-Rogacz Angelika Walder Nadja Schubert | 2023/6/9 |
TOBF1 modulates mouse embryonic stem cell fate through regulating alternative splicing of pluripotency genes | Cell Reports | Meghali Aich Asgar Hussain Ansari Li Ding Vytautas Iesmantavicius Deepanjan Paul | 2023/10/31 |
CRISPR/Cas9 Screen in Gastric Cancer Patient‐Derived Organoids Reveals KDM1A‐NDRG1 Axis as a Targetable Vulnerability | Small Methods | Jovan Mircetic Aylin Camgöz Moustafa Abohawya Li Ding Julia Dietzel | 2023/6 |
PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE-LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS | HemaSphere | Elisa Donato Nadia Correia Carolin Andresen Darja Karpova Roberto Würth | 2023/8/1 |
RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations | Cells | Olga Alexandra Sidorova Shady Sayed Maciej Paszkowski-Rogacz Michael Seifert Aylin Camgöz | 2022/3/2 |
Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling | Cellular Oncology | Sara Vanessa Bernhard Katarzyna Seget-Trzensiok Christian Kuffer Dragomir B Krastev Lisa-Marie Stautmeister | 2022/2 |
